PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
14.60%
Revenue growth 50-75% of CRWV's 23.55%. Martin Whitman would scrutinize if slower growth is temporary.
27.05%
Cost growth 1.25-1.5x CRWV's 19.16%. Martin Whitman would scrutinize competitive cost position.
9.44%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-4.50%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
13.85%
R&D change of 13.85% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
17.75%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
32.19%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
8.33%
Other expenses growth less than half of CRWV's 19.33%. David Dodd would verify if advantage is sustainable.
23.18%
Operating expenses growth 1.25-1.5x CRWV's 17.97%. Martin Whitman would scrutinize control.
24.90%
Total costs growth 1.25-1.5x CRWV's 18.28%. Martin Whitman would scrutinize control.
-3.43%
Interest expense reduction while CRWV shows 1.19% growth. Joel Greenblatt would examine advantage.
38.80%
D&A growth 1.25-1.5x CRWV's 26.15%. Martin Whitman would scrutinize asset base.
21.71%
EBITDA growth 50-75% of CRWV's 33.05%. Martin Whitman would scrutinize operations.
-11.37%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-7.05%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-18.90%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
658.82%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-5.46%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-17.51%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
51.50%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
-18.52%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-28.90%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-17.65%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-19.12%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.46%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.26%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.